Researchers report that performance standards set by federal health officials may have led to many patients being dropped from transplant lists without an improvement in survival rates.
The organ donor and both recipients in the procedure this month were all HIV-positive — a first in the U.S. Using HIV-positive organs for some patients could enable a thousand more transplants a year.
Effective treatments for hepatitis C cost as much as $95,000. Medicaid in many states, including Indiana, is mostly limiting the drugs' use to very advanced cases. ACLU of Indiana is suing the state.